The invasive properties of cancer cells depend on their intrinsic motile potential and on their ability to breach the endothelial barrier. In the present work, we investigated the mechanisms by which adhesion of colon cancer cells to E-selectin expressed by endothelial cells regulates the barrier function of these cells and modulates transmigration of cancer cells. We found that the stimulation of E-selectin by activating antibodies or the adhesion of HT-29 cells results in an increase in the activity of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinases. In turn, the activation of p38 and ERK enhances transendothelial permeability and migration of HT-29 cells. We also obtained evidence suggesting that p38-mediated increase in transendothelial migration of cancer cells depends on a myosin light chain phosphorylation-mediated formation of stress fibres. On the other hand, the activation of ERK by E-selectin modulates the opening of interendothelial spaces by initiating the activation of Src kinase activities and the dissociation of the VE-cadherin/b-catenin complex. We conclude that activation of E-selectin by adhering cancer cells is an important process that regulates the extravasation of colon cancer cells by initiating p38-and ERK-dependent mechanisms that both contribute to regulate the integrity of the endothelial layer.
Introduction
Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to the endothelium. It requires specific interactions between adhesion receptors present on vascular endothelial cells and their counter-receptors on cancer cells (Haier and Nicolson, 2001 ). These adhesive interactions induce a reverse signalling in the cancer cells that increases their motile potential and a forward signalling in endothelial cells that elicits breaches in the endothelium layer (Hu et al., 2000; Laferrie`re et al., 2001; Weis et al., 2004) . However, in both cases the signalling mechanisms involved are still ill defined.
E-selectin is an important adhesion receptor whose expression at the surface of endothelial cells is induced by inflammatory cytokines, such as interleukin-1b (IL-1b) and tumour necrosis factor-a (TNF-a) (Bevilacqua et al., 1987) . The physiological role of E-selectin is to mediate the rolling of neutrophils, monocytes and memory T cells on the endothelium enabling their extravasation at sites of inflammation (Kansas, 1996) . Several evidence indicate that colon cancer cells and other types of cancer cells parasite the inflammatory system and interact with E-selectin to facilitate their adhesion and extravasation, thus promoting invasiveness (Dejana et al., 1992; Yamada et al., 1995; Brodt et al., 1997; Krause and Turner, 1999) . For instance, the binding efficiency of clonal cancer cell lines to E-selectin is directly proportional to their respective metastatic potential (Sawada et al., 1994) . Moreover, the expression of E-selectin is inhibited by cimetidine or c-Raf antisense oligonucleotides, which correlates with inhibition of metastasis (Kobayashi et al., 2000; Khatib et al., 2002) . Analogously, Lewis lung carcinoma cells trigger the expression of E-selectin by liver sinusoidal endothelium, increasing their metastatic potential and suggesting that E-selectin contributes to the organ-specificity of metastatic colonization (Khatib et al., 1999) . Taken together, these studies point to a key role played by E-selectin-mediated endothelial adhesion in metastasis.
Most of the times, cancer cells must infiltrate the endothelium and extravasate from the blood vessel to form metastasis. This requires an increase in transendothelial permeability, a highly regulated process that involves weakening of cell adhesion to extracellularmatrix, loss of cellular junctions and the active or passive retraction of the endothelial cells (Baldwin and Thurston, 2001 ). The process is reversible, which indicates that endothelial cells can restore tight and adherens junctions following their dissolution. Many studies have demonstrated that regulation of endothelial cell permeability depends on the activation of several signalling pathways involving PKC members, Src tyrosine kinases and the small GTPases of the Rho family (Bogatcheva et al., 2002; Wojciak-Stothard and Ridley, 2002) . More recently, the p38 and extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinases have been identified as important molecules that regulate cellular tension and integrity of endothelial junctions (Kevil et al., 1998 (Kevil et al., , 2001 Verin et al., 2000; Wang and Doerschuk, 2001; Yao et al., 2001; Borbiev et al., 2004) . Moreover, several studies have shown that the activation of E-selectin induces signalling in the endothelial cells that leads to activation of ERK and p38 (Hu et al., 2000; Hu et al., 2001; Yoshida et al., 2003) . However, nothing is known as to whether or not E-selectin-mediated signalling in endothelial cells controls transendothelial permeability and migration of cancer cells.
We report that activation of E-selectin by adhering cancer cells is an important mechanism that regulates their transendothelial migration by initiating p38-and ERK-dependent opening of interendothelial contacts.
Results
Activation of E-selectin by crosslinking antibodies or adhesion of colon cancer cells triggers the activation of ERK and p38 MAP kinases in endothelial cells Transendothelial migration of colon cancer cells depends on motogenic signals that result from their adhesion to E-selectin expressed by endothelial cells (Laferrie`re et al., 2001) . In the present work, we investigated whether the adhesion of colon cancer cells to E-selectin also induced in endothelial cells a forward signalling that leads to the formation of breaches in the endothelial layer, thereby facilitating invasiveness.
The ERK and p38 MAP kinase pathways are centrally involved in transmitting signals that converge on the regulation of cell permeability following activation of adhesion receptors (Verin et al., 2000; Yoshida et al., 2003) . We thus verified whether these pathways are activated in response to stimulation of E-selectin on endothelial cells. Human umbilical vein endothelial cells (HUVEC) cultivated as monolayers were stimulated with IL-1b to induce maximal expression of E-selectin. Then, E-selectin was activated by using a system of activating antibodies. Briefly, the cells were incubated for 30 min with increasing concentrations of the anti-E-selectin mAb H18/7 followed by a single incubation with a crosslinking goat anti-mouse IgG for another 30 min. We found that neither the anti-E-selectin H18/7 antibody nor the goat anti-mouse IgG activated p38 or ERK when administered alone (data not shown). However, the crosslinking procedure resulted in a marked activation of the phosphorylation of both kinases that reached a peak with 45 mg/ml of the anti-E-selectin antibody (Figure 1a and b) . Time course analysis of phosphorylation of both ERK and p38 proteins after activation of E-selectin by incubation with 45 mg of antibody indicates that the activation of the kinases starts at 10 (ERK) or 20 (p38) minutes, reaches a peak at 30 min and then declines after 40 min (Figure 1c and d) . We next verified whether the adhesion of colon cancer cells HT-29 to HUVEC also initiated the activation of E-selectin and then of ERK and p38 in the endothelial cells. In this set of experiments, HT-29 cells were previously fixed with 2% paraformaldehyde to highlight the activation of the MAP kinases of solely endothelial cells (Hu et al., 2000; Laferrie`re et al., 2004) . Then, fixed HT-29 cells were added to E-selectin-expressing HUVEC for increasing intervals of time and the activation of p38 and ERK was determined. Results showed that the kinetics of activation of both kinases by HT-29 cells follows a typical bell-shape curve with a peak of activation of fourfold at 10 min of HUVEC exposure to HT-29 cells (Figure 2a and b) . Moreover, the effect was totally E-selectin dependent being impaired in the presence of H18/7, an antibody that used alone prevents E-selectin-mediated adhesion of HT-29 on HUVEC (Figure 2a and b) . Interestingly, the H18/7 antibody did not influence by itself the phosphorylation level of the kinases (Figure 2a and b).
Activation of E-selectin is associated with p38 and ERK-dependent increase in transendothelial permeability and migration of HT-29 cancer cells To ascertain the role of E-selectin in regulating transendothelial permeability, HUVEC expressing or not E-selectin were cultivated as tight monolayers on a 0.4 mm pore size gelatinized polycarbonate membranes separating the two parts of a 6.5 mm Boyden-modified chambers. The cells were treated or not with the E-selectin crosslinking antibodies procedure to activate E-selectin. Then, the permeability to bovine serum albumin (BSA)-Alexa was determined. Results showed that activation of E-selectin induced a 1.4-fold in the permeability to BSA-Alexa. Similar increase was induced by histamine used as a positive control (Figure 3) . Interestingly, we found that inhibiting p38 activity with SB203580 and ERK activation with PD098059 impaired the E-selectin-induced increase in transendothelial permeability highlighting that both ERK and p38 were involved in transducing signals that regulate transendothelial permeability in response to E-selectin activation.
Consistent with the fact that increased endothelial permeability was permissive to extravasation of cancer cells, we found that transendothelial migration of HT-29 cells was increased by 2.2-fold when HT-29 cells were added to a layer of HUVEC that expressed E-selectin. This increase was completely blocked by inhibiting E-selectin with the H18/7 neutralizing antibody suggesting that activation of E-selectin is the trigger of transendothelial migration. More importantly, transendothelial migration, as permeability, was impaired following 45 min pretreatments of HUVEC with SB203580 and PD098059 to inhibit p38 activity and ERK activation and it was reduced to below basal level, when both SB203580 and PD098059 were added concomitantly (Figure 4 ). This indicates that both ERK and p38 act synergistically to regulate transendothelial migration of HT-29 cells. Intriguingly, transendothelial migration of cancer cells was also impaired by inhibiting cell contractility and actin cytoskeleton integrity with ML-7 and cytochalasin D, respectively (Figure 4) . Overall, these results are consistent with the hypothesis that increased transendothelial permeability is a permissive event for transendothelial migration of cancer cells and that p38 and ERK pathways are major complementary pathways that regulate these events.
Mechanisms by which E-selectin regulates transendothelial permeability and migration of colon cancer cells We investigated next the mechanisms by which Eselectin-mediated activation of p38 and ERK regulates transendothelial permeability and migration of HT-29 cells. Given that signalling to actin cytoskeleton is prerequisite to endothelial cell contraction and permeability, we ascertained whether activation of Eselectin triggered signalling to actin. The E-selectin expressing-HUVEC were treated or not with the crosslinking activating antibody system. Then, they were processed for F-actin as well as for unactivated or activated E-selectin staining. As shown in Figure 5 , nonactivated E-selectin was distributed randomly at the cell periphery and showed a marked concentration in the perinuclear area (Figure 5a-c) . Moreover, it did not colocalize with F-actin that was mostly found at the periphery of the cells (Figure 5b and c) . Following activation of E-selectin, actin quickly remodelled to form patches at cell-cell contacts (arrows) and started to reorganize into thin transcytoplasmic stress fibres ( Figure  5d-f) . Concomitantly, E-selectin quickly relocalized at cell-cell junctions where it co-localized with spots rich in F-actin (Figure 5d-f) . Overall, these results indicate that HUVEC were stimulated with 20 ng/ml of IL-1b for 4 h. Thereafter, the cells were exposed for 30 min at 41C to increasing concentrations of H18/7 anti-E-selectin antibody. Next, the cells were treated with a single concentration of goat anti-mouse antibodies for 30 min at 371C. (c, d) HUVEC were stimulated with 20 ng/ml of IL-1b for 4 h. Thereafter, the cells were exposed for increasing periods of time to 45 mg of H18/7 anti-E-selectin antibody followed by a single concentration of goat anti-mouse antibodies for increasing periods of time at 371C. After treatments, ERK (a, c) and p38 (b, d) activation was determined in Western blot using phosphospecific antibodies. Results are the mean7s.d. of three separate experiments. Representative autoradiograms are shown.
activation of E-selectin in endothelial cells triggers its association with F-actin and initiates cellular remodelling. We next examined whether p38 and ERK pathways were involved in conferring the actin remodelling that may contribute to transendothelial permeability and migration of cancer cells in response to activation of E-selectin.
E-selectin-induced activation of p38 regulates transendothelial permeability and migration of cancer cells by mediating the formation of stress fibres The formation of stress fibres in endothelial cells is associated with an increased retraction of the cells and with a subsequent increase in interendothelial gaps and permeability (Saito et al., 1998; Tinsley et al., 1999) . We have previously shown that formation of stress fibres in response to oxidative stress and vascular endothelial growth factor (VEGF) is tightly associated with the activation of p38 Rousseau et al., 1997; Lamalice et al., 2004) . Hence, we examined the contribution of p38 in mediating the formation of stress fibres in response to E-selectin. E-selectin-expressing HUVEC following exposure to IL-1b were pretreated for 45 min with SB203580 before being treated with the crosslinking antibody system that activates E-selectin. Thereafter, the cells were processed for F-actin and total E-selectin staining, and examined in fluorescence microscopy. As previously reported in Figure 5 , results showed that activation of E-selectin induced an increase in the formation of stress fibres in addition to initiate its localization with patches of actin ( Figure 6a -f, see arrows). Moreover, the inhibition of p38 activity with SB203580 impaired the actin reorganization into stress fibres, and it modified the localization pattern of E-selectin (Figure 6g -i). In contrast, the inhibition of ERK had no effect on this actin signalling induced by activation of E-selectin (data not shown). These results suggest that the inhibition of transendothelial permeability and migration derives from the inhibition of p38-mediated formation of stress fibres. Interestingly, formation of stress fibres also requires phosphorylation of myosin light chain (MLC) to trigger the association of F-actin with myosin (Schnittler et al., 1990; Garcia et al., 1995; Baldwin and Thurston, 2001) . In this context, we found that the activation of E-selectin Figure 3 Activation of E-selectin increases transendothelial permeability -HUVEC were cultivated at confluence on a 0.4 mm pore size gelatinized polycarbonate membranes that separate the upper and bottom part of a 6.5 mm modified Boyden chamber. HUVEC were stimulated or not by 20 ng/ml IL-1b for 4 h. Fortyfive minutes before the end of treatment DMSO, PD09859 (P; 50 mM), or SB203580 (S; 5 mM) were added. Thereafter, the medium was changed for fresh one containing BSA-Alexa-488 in the upper chamber and E-selectin was activated using the E-selectin antibody (H18/7), and the clustering antibody or treated with an irrelevant antibody (MOPC21) in the presence or not of the specific inhibitors. After 50 min, aliquots were taken from the bottom chamber to evaluate permeability by measuring the fluorescence. Histamine (5 mM) was used as positive control. Results are the mean7s.d. of three separate experiments.
induced a B3-fold increase in the phosphorylation of MLC. The E-selectin-mediated phosphorylation of MLC was sensitive, not only to ML-7 but, also to SB203580 and to inhibition of actin polymerization by a low concentration of cytochalasin-D (Figure 6j and k) . Overall, the findings suggest that p38 modulated transendothelial permeability and migration of cancer cells by ensuring the formation of stress fibres in a process that required phosphorylation of MLC.
E-selectin-mediated activation of ERK regulates transendothelial permeability and migration of cancer cells by regulating the Src-dependent dissociation of the VE-cadherin/b-catenin complex Adherens junctions are major structures involved in the regulation of transendothelial permeability and migration of cancer cells and leucocytes across a monolayer of endothelial cells including HUVEC (Baldwin and Thurston, 2001; Yuan, 2002; Ionescu et al., 2003; Peng et al., 2005) . As a major component of adherens junctions, VE-cadherin connects adjacent endothelial cells through its extracellular domain, whereas its intracellular domain interacts with actin cytoskeleton via a family of catenins namely b-catenin (Dejana et al., 1999) . Dissociation of the VE-cadherin/b-catenin complex induces endothelial barrier dysfunction and contributes to transmigration of cancer cells in response to VEGF (Dejana et al., 2001; Weis et al., 2004) . Using co-immunoprecipitation assays, we found that the activation of E-selectin in HUVEC resulted within 10 min in a transient dissociation of the VE-cadherin/b-catenin complex (Figure 7a ). To ascertain whether ERK and p38 MAP kinase activation by E-selectin modulated the signals that lead to the dissociation of the VE-cadherin/ b-catenin, we evaluated the effects of E-selectin activation in cells that have been treated with SB203580 or PD098059. As shown in Figure 7b , we found that Activation of E-selectin is associated with an increase in transendothelial migration of colon cancer cells HT-29 -HUVEC were grown to confluence on a 8.0 mm pore size gelatinized polycarbonate membrane separating the two compartments of a 6.5-mm Fluoroblokt chamber. HUVEC were treated or not with 20 ng/ml IL-1b for 4 h. Forty-five minutes before the end of treatment, DMSO or the following inhibitors were added: PD09859 (P; 50 mM), SB203580 (S; 5 mM), ML-7 (M; 25 mM), cytochalasin D (C; 50 nM). Culture media in the migration chamber were changed for fresh media and HT-29 cells labelled with Calcein-AM were added on the upper face of the membrane with or without 15 mg/ml of E-selectin antibody for an additional 16 h. Cells that have crossed the opaque membranes were then counted in a fluorescence microscope. Results are the mean7s.d. of three separate experiments.
Figure 5 Activated E-selectin associates with F-actin at cell-cell junctions -HUVEC were stimulated with 20 ng/ml IL-1b for 4 h. Thereafter, the cells were (d-f) or not (a-c) exposed to the E-selectin activating antibody system as described in Figure 1 . F-actin was detected by phalloidin isothiocyanate conjugated with fluorescein (b, c, e, f). Unactivated E-selectin was detected using monoclonal antibody (H18/7) (a, c). Then, the antigen-antibody complex was revealed using a goat anti-mouse antibody conjugated with Alexa-568. Detection of activated E-selectin, was performed by using a donkey IgG anti-goat antibody conjugated to biotin to bind the crosslinking antibody and then was revealed with Texas Red-conjugated streptavidin (d, f). The cells were examined with the use a Nikon Disphot-TDM confocal microscope equipped with a Â 60 objective. Representative fields are shown. Arrows show colocalization of actin and E-selectin.
PD098059 but not SB203580 inhibited the E-selectinmediated dissociation of the VE-cadherin/b-catenin complex. These results suggest that E-selectin-mediated activation of ERK contributes to regulate transendothelial permeability and migration of cancer cells by triggering the dissociation of the VE-cadherin/b-catenin complex. The dissociation of the VE-cadherin/b-catenin has been attributed to Src kinase-mediated phosphorylation of b-catenin on tyrosine residues (Weis et al., 2004) . Consistent with this possibility, PD098059, as the Src kinase inhibitor PP2, inhibited the activation of Src kinases in response to activation of E-selectin (Figure 7c) . Moreover, the inhibition of Src kinase activities with PP2 inhibited the dissociation of the VE-cadherin/b-catenin complex (Figure 7d ). These findings suggest that E-selectin-mediated activation of ERK is upstream of Src-dependent regulation of the VE-cadherin/b-catenin complex integrity. Considering that c-Src is involved in regulating vascular permeability (Criscuoli et al., 2005) , we ascertained whether it was the Src member that controlled the dissociation of the VE-cadherin/b-catenin complex. HUVEC were electro- Figure 6 p38-mediated formation of stress fibres in response to activation of E-selectin -HUVEC were stimulated with 20 ng/ml IL1b for 4 h. Forty-five minutes before the end of treatments DMSO (a-f) or SB203580 (5 mM) (g-i) were added in the medium. Thereafter, HUVEC were (d-i) or not (a-c) exposed to the E-selectin activating antibody system as described in Figure 1 . F-actin was detected by phalloidin isothiocyanate conjugated with fluorescein (b, c, e, f, h and i). Total E-selectin was detected using the monoclonal antibody (H18/7) (a, c, d, f, g, i). The antigen-antibody complex was detected by a goat anti-mouse antibody conjugated with Alexa-568. The cells were examined with the use of Nikon Eclipse E800 fluorescence equipped with a Â 40 objective. Representative fields are shown. Phosphorylation of MLC was determined in j and k. HUVEC were stimulated with 20 ng/ml IL-1b for 4 h. Forty-five minutes before the end of treatment DMSO or the following inhibitors were added in distinct wells: SB203580 (S; 5 mM), cytochalasin D (C; 50 nM), ML-7 (M; 25 mM). Thereafter, HUVEC were exposed or not to the E-selectin activating antibody system. Phosphorylation of MLC was determined in Western blot using a phosphospecific antibody. Results are the mean7s.d. of two separate experiments. Representative autoradiograms are shown. Arrows show E-selectin at cell-cell junctions. Figure 7 E-selectin-mediated activation of ERK regulates the Src-dependent dissociation the VE-cadherin/b-catenin complex -HUVEC were stimulated with 20 ng/ml IL-1b for 4 h. Thereafter, the cells were exposed to E-selectin antibody for 30 min at 41C, and then were treated for different time intervals with a goat anti-mouse antibody crosslinking antibody at 371C (a). In (b-e) the procedure was the same except that the cells were exposed to a single period of time of 30 min to the goat anti-mouse antibody. In (b) PD09859 (P; 50 mM), SB203580 (S; 5 mM) or DMSO were added in distinct dishes 45 min before the use of the activation antibody system in the culture medium and a co-immunoprecipitation of VE-cadherin/b-catenin was performed. An irrelevant antibody (MOPC21) was used as a negative control. In (c) inhibitors PP2 (10 mM), PD09859 (P; 50 mM) were added like in (b). Then Src kinase activities were determined in Western blot using phosphospecific antibody. (d) Cells exposed or not to PP2 were treated with the E-selectin activating antibody system and the dissociation of VE-cadherin/b-catenin complex was determined in inmmunoprecipitation as in (b). In (e) HUVEC were transfected by electroporation with an empty vectors (MOCK) or with pLNCX vectors expressing wt c-Src, constitutive active c-Src (Y527F) or DN c-Src (K295R). Thereafter, they were treated with the E-selectin activating antibody system and the dissociation of VE-cadherin/b-catenin complex was determined in inmmunoprecipitation as above. Results are the mean7s.d. of two separate experiments. Representative autoradiograms are shown.
VE-cadherin
porated with plasmids expressing wt form, constitutive active (Y527F) or dominant-negative (DN) forms of c-Src (K295R). Thereafter, the expression of E-selectin was induced, E-selectin was activated, and the dissociation of the VE-cadherin/b-catenin complex was determined. We found that the dissociation was impaired by the DN c-Src (Figure 7e ). The inhibition was partial, presumably because only 30% of the cells expressed DN c-Src or because another member of the Src family is involved. Yet, the expression of wt c-Src or its constitutive active form synergized with E-selectin to dissociate the VE-cadherin/b-catenin complex indicating that c-Src is importantly involved in the process.
Discussion
E-selectin is a specific endothelial transmembrane adhesion receptor whose expression is inducible following a challenge by proinflammatory stimuli (Laferrie`re et al., 2002) . The usual role of E-selectin is to mediate the adhesion of leucocytes to the endothelium allowing their extravasation into inflamed tissues (Vestweber and Blanks, 1999) . Several lines of evidence indicate that cancer cells 'parasite' the inflammatory system and interact with E-selectin to extravasate from blood vessel and form metastases. In particular, adhesion of colon cancer to E-selectin is a key determinant of metastasis (Laferrie`re et al., 2001; Khatib et al., 2002) . This relies in part on the fact that adhesion to E-selectin enhances the metastatic potential of colon cancer cells by increasing their intrinsic motile potential through activation of an E-selectin counter-receptor present on HT-29 cells (Laferrie`re et al., 2001) . In our present work, we show that E-selectin itself is activated following the adhesion of cancer cells, which initiates the activation of MAP kinases in endothelial cells and triggers cellular remodelling that causes breaches in the endothelial layer enabling extravasation. The notion that E-selectin induces a forward signalling in endothelial cells has previously been supported by studies showing that the adhesion of LS174T colon adenocarcinoma to E-selectin-expressing HUVEC initiate the endocytosis of E-selectin (Burdick et al., 2003) . It is also supported by studies reporting that activation of E-selectin by crosslinking activating antibodies or adhesion of HL-60 leukaemia cell induces the clustering of E-selectin and triggers the activation of ERK and p38 in endothelial cells (Yoshida et al., 1996; Hu et al., 2000 Hu et al., , 2001 Yoshida et al., 2003) . Activation of ERK derives from the phosphorylation of Tyr603 within E-selectin by an unknown kinase (Hu et al., 2001) . Our finding that HT-29 cells also leads to an E-selectin-dependent activation of p38 and ERK in endothelial cells is the first demonstration that E-selectin is activated in response to adhesion of cancer cells from solid tumours. This observation is important because it expands the notion that E-selectin is a signalling receptor and because it greatly contributes in opening new avenues for the understanding of the metastatic process in the case of solid tumours.
A major novel contribution of our study is to show that the E-selectin-mediated activation of p38 and ERK may regulate transendothelial permeability and transendothelial migration of cancer cells by regulating the formation of stress fibres and the dissociation of the VE-cadherin/b-catenin complex.
The fact that p38 may regulate transendothelial permeability and migration of HT-29 cells by inducing the formation of stress fibres is suggested by the observation that its inhibition is associated with a blockade in the formation of stress fibres as well as in transendothelial permeability and migration of cancer cells. Stress fibres are constituted of an association of actin with myosin (Zhong et al., 1998) . The association is triggered by the phosphorylation of myosin light chain in response to increase contractile forces generated in the cells by actin polymerization (Mehta and Gunst, 1999; Houle et al., 2003; Shaw et al., 2003) . In accordance, we found that phosphorylation of MLC is impaired by inhibiting actin polymerization by cytochalasin D. Given that p38 activation mediates actin polymerization in response to VEGF and oxidative stress (Huot et al., , 1998 Rousseau et al., 1997 Rousseau et al., , 2000 , our results suggest that the activation of p38 induces the formation of stress fibres and thereby interendothelial opening by leading to actin-polymerization-mediated phosphorylation of MLC. Of note, p38 exists under four different isoforms (p38a, p38b, p38g and p38d) (Hale et al., 1999) . However, SB203580 inhibits the activity of only the a and b isoforms, which indicates that these isoforms of p38 and not the g and d isoforms are responsible for the E-selectin-induced formation of stress fibres. Overall our findings highlight for the first time that both the contribution of MLC and p38 to stress fibre formation and contraction are required for opening of interendothelial spaces.
As previously mentioned, the adherens junctions are major structures involved in regulating migration of cancer cells across endothelial cells including HUVEC (Peng et al., 2005) . As the primary component of adherent junctions, VE-cadherin connects adjacent endothelial cells through its extracellular domain, whereas its intracellular domain interacts with actin cytoskeleton via a family of catenins (Dejana et al., 1999) . Dissociation of the VE-cadherin/b-catenin complex is associated with endothelial barrier dysfunction (Dejana et al., 2001) . Along these lines, we found that activation of E-selectin disrupts the VE-cadherin/ b-catenin complex, which may contribute to its role in inducing transendothelial permeability. The fact that ERK controls transendothelial migration of cancer cells by regulating the dissociation of the VE-cadherin/ b-catenin complex is supported by our finding that its inhibition impairs both processes. The tyrosine phosphorylation of b-catenin is known to perturb cadherinmediated adhesion by disrupting VE-cadherin/b-catenin interaction (Brembeck et al., 2004) . Member of the Src tyrosine kinase family are known to be involved in modulating the dissociation of the VE-cadherin/ b-catenin complex (Roura et al., 1999; Owens et al., 2000) . Accordingly, we found that the PP2-mediated inhibition of Src kinase activities is associated with an inhibition of the E-selectin-mediated dissociation of the VE-cadherin/b-catenin complex. This raises the possibility that activation of the ERK pathway is upstream of Src activation. In accordance, we report for the first time that inhibiting MEK activity with PD098059 inhibited the activation of Src kinases by E-selectin. Hence, our results support the view that the ERK pathway regulates transendothelial permeability and transendothelial migration by modulating the Src-dependent dissociation of the VE-cadherin/b-catenin complex in response to E-selectin activation. Considering that PP2 is a pan-Src kinase activity inhibitor and that the DN c-Src exerts a partial effect, it is difficult to firmly ascertain which member of the Src family is involved in transducing the E-selectin signal that regulates the integrity of the VEcadherin/b-catenin complex. Nevertheless, our finding that constitutive active form of c-Src synergizes with E-selectin suggests that c-Src is a major player.
In summary, we demonstrated for the first time that activation of E-selectin is an important regulator of the endothelial barrier integrity. Its activation by colon cancer cells triggers the activation of both p38 and ERK MAP kinases, which induces a cytoskeletal remodelling that induces breaches in the endothelial layer, thus facilitating the extravasation of adhering cancer cells. These findings highlight a new mechanism by which the adhesion of cancer cells to endothelial cells may regulate the metastatic process.
Materials and methods

Reagents
Recombinant human IL-1b, PD09859, SB203580 and PP2 were purchased from Calbiochem (Mississauga, Canada). ML-7 and cytochalasin D were obtained from Sigma (St Louis, MO, USA). Calcein AM and BSA-Alexa-488 were obtained from Invitrogen-Molecular Probes (Burlington, Canada). Protein A-Sepharose was purchased from Amersham Biosciences (Baie d'Urfe´, Canada). Plasmids expressing wt c-Src, constitutive active c-Src (Y527F) and dominant-active c-Src (K295R) were in pLNX vector (Joan Brugge: Harvard Medical School).
Antibodies
Mouse IgG k (MOPC21) was purchased from Sigma. Goat IgG anti-mouse Alexa-568 was obtained from Invitrogen-Molecular Probes. Donkey IgG (H þ L) anti-goat conjugated with biotin, goat anti-mouse IgG (H þ L) conjugated with horseradish peroxidase and goat anti-rabbit IgG (H þ L) conjugated with horseradish peroxidase were purchased from Jackson ImmunoResearch (West Grove, PA, USA). H18/7 was obtained from ATCC (Manassas, VA, USA). Rabbit antiphospho-Src was purchased from Biosource International (Camarillo, CA, USA). Rabbit polyclonal anti-b-catenin, rabbit polyclonal anti-c-Src (Src2) and mouse monoclonal anti-VE-cadherin were all purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclonal antiphospho ERK MAP kinase, rabbit polyclonal anti-phospho Myosin Light Chain 2, rabbit polyclonal anti-Myosin Light Chain 2, rabbit polyclonal anti-phospho p38 MAP kinase were purchased from Cell Signalling Technology (Beverly, MA, USA). Rabbit polyclonal anti-ERK MAP kinase and rabbit polyclonal p38 MAP kinase are gifts from Drs John Groce and Jacques Landry (Universite´Laval, Que´bec, Canada). Cells HUVEC were isolated by collagenase digestion of umbilical veins from undamaged sections of fresh cords . After isolation, the cells were washed and plated on gelatine-coated culture dishes in medium 199 containing 20% heat-inactivated foetal bovine serum (FBS), endothelial cell growth supplement (60 mg/ml), glutamine (2 mM), heparin (25 000 IU) and antibiotics. Replicated cultures were obtained by trypsinization and were used at passages p5. HT-29 human colon carcinoma cells were obtained from ATCC. They were cultivated in McCoy 5A medium supplemented with 10% FBS and antibiotics. Cultures were kept at 371C in a humidified atmosphere containing 5% CO 2 .
Transfection Gene transfer in HUVEC was performed by electroporation as previously described (Le Boeuf et al., 2004) . Suspended cells were mixed with DNA (30 mg of DNA construct/10 6 cells). Then, cells were left at room temperature for 3 min in electroporation buffer at 200 mosmol/kg (42% Hypoosmolar, 58% Isoosmolar Eppendorf electroporation buffer, Brinkman, Westbury, NY) and were electroporated at 670 V for 100 ms using an Eppendorf Multiporatort. Cells were left at room temperature for an additional 10 min and were plated in complete media in 100-mm Petri dishes. After 4 h, media were changed for fresh media. After 24 h, the cells were made quiescent for 16 h and then were treated and processed as described below. Co-transfection of a green fluorescent protein (GFP) construct makes it possible to evaluate transfection efficiency as 30% following determination of the percentage of cells that express GFP under the fluorescence microscope.
Expression and activation of E-selectin
The synthesis of E-selectin in HUVEC was induced by exposure to 20 ng/ml of IL-1b for 4 h at 371C. The activation of E-selectin was triggered by a crosslinking antibody procedure (Hu et al., 2000) . It consists of treating HUVEC with the E-selectin antibody H18/7 for 30 min at 41C, followed by an exposure to a goat anti-mouse antibody for increasing periods of times at 371C. This initiates the crosslinking of the H18/7/E-selectin complex and leads to E-selectin activation. E-selectin on E-selectin-expressing HUVEC was also activated by the addition of HT-29 cells previously fixed for 20 min with 2% paraformaldehyde. Then, HUVEC were treated or not with E-selectin antibody H18/7 for 30 min at 41C, followed by an exposure to fixed HT-29 for an additional 30 min and then transferred at 371C for increasing time intervals.
MAP kinase activation
The MAP kinase activation was assayed in Western blots using phosphospecific antibodies (Lamalice et al., 2004) .
Western blot analysis
Cells were lysed on ice in Laemli buffer. Then, lysates were boiled 5 min and proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After washing and blocking procedures, the nitrocellulose membranes were incubated overnight at 41C with specific antibodies. Thereafter, the membranes were washed three times for 5 min in Tris buffer containing 0.1% Tween. An additional blocking procedure was performed for 45 min. Then, the nitrocellulose membranes were incubated in the presence of appropiate antibodies. Blots were then developed with ECL (Amersham Biosciences). Quantification of the immunoreactive bands was performed by densitometric scanning using NIH Image software.
Transendothelial permeability assay HUVEC were grown to confluence on top of gelatinized 0.4 mm pore size polycarbonate membranes that separate the upper and lower part of 6.5 mm modified Boyden migration chambers (Transwell, Costar). The expression of E-selectin was induced by exposure to 20 ng/ml IL-1b for 4 h. For the last 45 min, HUVEC were pretreated with the inhibitors PD09859 or SB203580 or the vehicle dimethylsulphoxide (DMSO) (0.05%). Thereafter, the medium was changed for fresh one containing BSA-Alexa-488 in the upper chamber and Eselectin was activated using the crosslinking antibody procedure or the cells were treated with an irrelevant antibody (MOPC21) in the presence or not of the specific inhibitors. After 50 min, aliquots were taken from the bottom chamber and the fluorescence was measured using a Fluorokan Ascent FL (Thermo Electron Corporation, Calgary, Canada).
Transendothelial cell migration assay HUVEC were grown to confluence for 72 h on a 8.0-mm pore size gelatinized polycarbonate membranes separating the two compartments of Fluoroblokt (BD Bioscience, Flanklin Lakes, NJ, USA) modified Boyden chambers. HUVEC were treated or not with 20 ng/ml IL-1b for 4 h to induce the expression of E-selectin. Meanwhile, tumour cells in suspension were labelled for 30 min with Calcein-AM (1 mM) and washed twice with M199 medium. For the last 45 min, HUVEC were pretreated with the inhibitors SB203580, PD098059, ML-7, cytochalasin D or vehicle DMSO (0.05%). Thereafter, culture media were changed for fresh media and 150 000 HT-29 cells, with or without 15 mg of anti-E-selectin antibody (H8/7) or irrelevant antibody (MOPC21), were added for an additional 16 h on the upper face of the membrane. Then, the number of HT-29 cells that have migrated to the lower face of the filter was counted with a fluorescence microscope TE2000 microscope using Â 20 magnification (Nikon, Melville, NY, USA).
Co-immunoprecipitation
After treatments, cells were scraped and extracted in lysis buffer containing Tris pH 7.5, 150 mM NaCl, 2 mM CaCl 2 , 1 mM leupeptin, 1 mM Na 3 VO 4 , 1 mM benzamidin, 50 mM NaF, 0.1% Triton X-100, 1 mM phenylmethylsulphonyl fluoride and 2.4 mM of deoxycholic sodium salt. After centrifugation at 41C, the clarified supernatants were precleaned with 30 ml of protein A-Sepharose 50% v/v in lysis buffer for 30 min. The samples were centrifuged again and the supernatants were incubated overnight with 10 mg of anti-b-catenin antibody. Then 30 ml of protein A-Sepharose 50% v/v in lysis buffer were added, and the mixtures were incubated for 3 h. Samples were washed three times with lysis buffer. Immunoprecipitates in TEX were directly used for Western blotting analysis using antibodies against VE-cadherin.
Confocal and fluorescence microscopy HUVEC were grown for 24 h on gelatineized LabTek. After E-selectin activation, by a crosslinking antibody system, the cells were fixed with formaldehyde 3.7% and permeabilized by a solution of PBS pH 7.5 containing 0.1% saponin. To specifically detect activated E-selectin, HUVEC were fixed and were incubated with a donkey IgG (H þ L) anti-goat antibody conjugated to biotin that binds the crosslinking antibody, which was followed by revelation with Texas Red-conjugated streptavidin. Then, the cells were examined with the use a Nikon Diaphot-TDM (Eclipse 2000) confocal microscope equipped with a Â 60 objective and the system Bio-Rad MRC-1024 (Nikon). To detect total E-selectin, Alexa-568 conjugated with goat IgG anti-mouse was used. F-actin was detected by phalloidin isothiocyanate conjugated with Alexa-488. The cells were examined by using a Nikon Eclipse E800 fluorescence microscope.
